Immunological Investigation on the adverse reaction of iodinated contrast media
碘造影剂不良反应的免疫学研究
基本信息
- 批准号:05454306
- 负责人:
- 金额:$ 3.46万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Our investigation during 1993 - 1994, showed a possible adjuvant effect on IgE antibody production in mice. In addition, the adjuvant effect is probably related to the induction immunological reaction of interleukin 4 (reported at contrast media research conference, Turku, Finland, in June 1995 and submitted to the British Journal of Radiology). In 1995, we thought that we should the confirm our previous results mentioned above, and perform a same procedure using nonionic dimeric contrast media, because delayd adverse reaction of nonionic dimeric contrast media became urgent medicosocial or medicolegal problems. The IgE antibody production was again evaluated, using new iodinated contrast media. In addition to iopamidol, we included to varieties of the nonionic dimeric contrast media (iotrolan and iodixanol) in our experiments. BALB/c male mice (8 weeks) are divided into eight experimental groups ; A saline B DNP-KLH + ALUM C DNP-KLH + ALUM + iopamidol D ALUM + iopamidol E DNP-KLM + ALUM + iotrolan F ALUM + iotrolan G DNP-KLH + ALUM + iodixanol H ALUM + iodixanol. Total IgE production was measured at pre-, one week, three weeks, and five weeks after immunization, by using ELISA technique. The results have not shown significant increase of total IgE among the eight experimental groups so far. Data analysis is still being continued.
我们在1993 - 1994年期间的研究表明,可能的佐剂作用的IgE抗体产生的小鼠。此外,佐剂效应可能与白细胞介素4的诱导免疫反应有关(1995年6月在芬兰图尔库的造影剂研究会议上报道,并提交给英国放射学杂志)。1995年,我们认为,我们应该确认我们以前的上述结果,并使用非离子型二聚造影剂进行相同的程序,因为非离子型二聚造影剂的延迟不良反应成为迫切的医学社会或法医学问题。使用新的碘化造影剂再次评价IgE抗体产生。除碘帕醇外,我们还在实验中纳入了各种非离子二聚体造影剂(iotrolan和碘克沙醇)。将BALB B/c雄性小鼠(8周)分成8个实验组:A盐水B DNP-KLH + ALUM C DNP-KLH + ALUM +碘帕醇D ALUM +碘帕醇E DNP-KLM + ALUM +碘曲兰F ALUM +碘曲兰G DNP-KLH + ALUM +碘克沙醇H ALUM+碘克沙醇。用ELISA法测定免疫前、免疫后1周、3周和5周的总IgE产生量。结果显示,到目前为止,八个实验组中的总IgE没有显著增加。数据分析仍在继续。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Miyauchi T. :"Anaphylactic IgE and IgG productions for hapten were enhanced by contrast media as an ajuvant : importance IL-4" British J.Radiology. (submitted).
Miyauchi T.:“作为佐剂的造影剂增强了半抗原的过敏性 IgE 和 IgG 产生:IL-4 的重要性”British J.Radiology。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Miyauchi T.: "Anaphylactic IgE and IgG_1 productions for hapten were enhanced by contrast media as an ajuvant : importance of IL-4" British J.Radiology. (投稿中).
Miyauchi T.:“造影剂作为佐剂增强了半抗原的过敏性 IgE 和 IgG_1 产生:IL-4 的重要性”British J.Radiology(已提交)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATAYAMA Hitoshi其他文献
KATAYAMA Hitoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATAYAMA Hitoshi', 18)}}的其他基金
Development of Formation Control Systems with Disturbance Rejection for Small Ships
小型船舶抗扰编队控制系统的开发
- 批准号:
21560459 - 财政年份:2009
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of Autopilot and Collision Avoidance Systems for Ships by Nonlinear Receding Horizon H_∞ Control Theory
非线性后退视界H_∞控制理论开发船舶自动舵及避碰系统
- 批准号:
18560428 - 财政年份:2006
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
In-silico Analysis of Adverse Reaction of Iodinated Contrast Media and Visualization of Carcinostatic Agent in Endovascular Therapy
血管内治疗中碘造影剂不良反应的计算机分析和抑癌剂的可视化
- 批准号:
22K12764 - 财政年份:2022
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Massive transfusion induced complement activation and its consequent adverse reaction in severe trauma patients
严重创伤患者大量输血引起的补体激活及其不良反应
- 批准号:
22K09163 - 财政年份:2022
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SEARCH (active Surveillance and Evaluation of Adverse Reactions in Canadian Healthcare) & PREVENT (Pharmacogenomics of Adverse Reaction EVEnts National Team)
SEARCH(加拿大医疗保健不良反应的主动监测和评估)
- 批准号:
379425 - 财政年份:2018
- 资助金额:
$ 3.46万 - 项目类别:
Operating Grants
The pharmacoepidemiological study on the adverse reaction of novel therapeutic agent for type 2 diabetes mellitus and the application
2型糖尿病新型治疗药物不良反应的药物流行病学研究及应用
- 批准号:
15K08124 - 财政年份:2015
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clarification of molecular mechanisms of chronic allograft nephropathy focusing on adverse reaction of immunosuppressive drugs, and survey of noninvasive markers
以免疫抑制药物不良反应为重点阐明慢性移植肾病分子机制及无创标志物调查
- 批准号:
15H04666 - 财政年份:2015
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
DSEN Pharmacogenomics of Adverse Reaction Events National Team (DSEN-PREVENT)
DSEN 不良反应事件药物基因组学国家小组 (DSEN-PREVENT)
- 批准号:
314437 - 财政年份:2014
- 资助金额:
$ 3.46万 - 项目类别:
Directed Grant
Establishment of assay system for vaccination adverse reaction and its clinical application.
疫苗不良反应检测体系的建立及其临床应用
- 批准号:
22580372 - 财政年份:2010
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SNP PROFILE OF RADIOSENSITIVE-RELEVANT GENES/ADVERSE REACTION IN PROSTATE CANCER
前列腺癌中放射敏感相关基因/不良反应的 SNP 谱
- 批准号:
7719630 - 财政年份:2008
- 资助金额:
$ 3.46万 - 项目类别:
Drug Transport in human erythrocyte membrane and drug interaction/adverse reaction in erythrocyte
人红细胞膜中的药物转运和红细胞中的药物相互作用/不良反应
- 批准号:
19590145 - 财政年份:2007
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Molecular Mechanism of Late Phase Adverse Reaction of Contrast Media
造影剂晚期不良反应的分子机制
- 批准号:
10671772 - 财政年份:1998
- 资助金额:
$ 3.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)